Eli Lilly
US allows 1st emergency use of a COVID-19 antibody drug
US health officials have allowed emergency use of the first antibody drug to help the immune system fight COVID-19, an experimental approach against the virus that has killed more than 238,000 Americans.
US drug maker Eli Lilly pauses antibody trial over safety concerns
US drug maker Eli Lilly said it has paused its trial of a combination antibody treatment for COVID-19 for safety reasons.